New & Notable
AMA's top 10 health recommendations for 2025
As the new year approaches, the AMA has released 10 recommendations aimed at helping individuals achieve meaningful and lasting health improvements in 2025 and beyond.
Analyzing therapeutic psychedelics: Opportunities, challenges
Experts at the 2024 WMIF discuss the challenges and opportunities associated with therapeutic psychedelics, including cost, access, continued innovation and patient management.
Advancing continuous manufacturing with FDA support
Continuous manufacturing is transforming pharmaceuticals with FDA support, bringing faster production, cost savings and improved quality to the industry.
USPSTF proposes guidelines for cervical cancer screening
With the advent of new self-collection methods for HPV testing, the USPSTF has proposed draft guidelines for cervical cancer screening that include patient-collected HPV tests.
Insights
Insights is the research division of Xtelligent Healthcare Media. Our work aims to leverage Xtelligent’s diverse readership of healthcare professionals across various sectors of the industry to understand real-world challenges and identify effective solutions.
Access All Reports
Healthcare Strategies: A Podcast
-
A podcast for healthcare professionals seeking solutions to today's and tomorrow's top challenges. Hosted by the editors of Xtelligent Healthcare Media, this podcast series focuses on real-world use cases that are leading to tangible improvements in care quality, outcomes, and cost.
Guests from leading provider, payer, government, and other organizations share their approaches to transforming healthcare in a meaningful and lasting way.
View All Episodes
Latest News
-
ARPA-H awards startup $3 million for home preeclampsia test
Gravidas Diagnostics received $3 million from ARPA-H to develop a home fingerstick preeclampsia test that detects sFlt‐1 levels in the bloodstream using a colorimetric assay.
-
Pharmacy closures pose risk for minority communities
A study analyzing trends in pharmacy closures found that closures exceeded pharmacy openings between 2018 and 2021, disproportionately impacting marginalized communities.
-
Zepbound outperforms Wegovy in weight loss clinical trial
Researchers comparing the safety and efficacy of Zepbound and Wegovy in a phase 3b clinical trial find that Zepbound might achieve better weight loss results than Wegovy.
-
FDA investigates E. coli outbreak in organic carrots
The FDA is investigating an E. coli outbreak linked to several brands of organic carrots that were recalled by Grimmway Farms for contamination with Shiga toxin-producing E. coli.
-
Over half of Americans won't get the new COVID-19 vaccine
Although over half of Americans do not plan to get the new COVID-19 vaccine for a range of reasons, perceptions vary based on political affiliation, age and race.
-
WHO, CDC report a 20% rise in global measles cases
The WHO and CDC emphasize the need for greater measles surveillance and targeted vaccination efforts to address the 20% rise in global measles cases from 2022 to 2023.
Features
-
2025 life sciences industry outlook: What's next?
A 2025 life sciences industry outlook report identifies several focus areas, including digital transformation, competitive pressures, business volatility and evolving customer needs.
-
Understanding the impact of food safety recalls, regulation
Food safety regulations are key to protecting public health, ensuring safe consumption and maintaining consumer trust amid complex global food systems.
-
Anticipating the healthcare reach of GLP-1 receptor agonists
Thought leaders at the 2024 WMIF discussed how cost, drug shortages, compounding pharmacies and insurance coverage for GLP-1 receptor agonists will impact the future landscape.
-
Exploring the secondary prevention of cervical cancer
Molecular tests, sampling, cytologic techniques, visual assessment and precancer treatment play a critical tool in the secondary prevention of cervical cancer.